BPG is committed to discovery and dissemination of knowledge
Prospective Study
©The Author(s) 2026.
World J Cardiol. Jan 26, 2026; 18(1): 111736
Published online Jan 26, 2026. doi: 10.4330/wjc.v18.i1.111736
Table 1 Demographic characteristics, comorbidities, atherosclerotic disease, and chronic therapy, n (%)
Variable
Occluded artery (n = 1687, 67.9%)
Patent artery (n = 796, 32.1%)
P value
Age (years)63 (55-73)66.3 (58-75)< 0.0001
Male sex1206 (72.9)572 (71.87)0.584
Comorbidities
Atrial fibrillation95 (5.7)65 (8.2)0.018
Arterial hypertension1176 (71.1)624 (78.4)< 0.0001
Diabetes mellitus346 (20.9)236 (29.6)< 0.0001
Family history of CV diseases545 (33.0)280 (35.2)0.649
Smoking676 (40.6)278 (34.9)< 0.001
BMI (kg/m2)27.8 (25.3-30.9)27.8 (25.0-30.5)0.388
Extent of atherosclerotic disease
Carotid stenosis60 (3.6)54 (6.8)< 0.0001
Peripheral artery disease89 (5.4)66 (8.3)< 0.005
Previous CABG26 (1.6)14 (1.8)0.735
Previous PCI140 (8.5)89 (11.2)0.030
Previous MI166 (10.0)117 (14.7)< 0.0001
Previous stroke83 (5.0)46 (5.8)0.427
Chronic therapy (> 4 weeks before AMI)
ASA269 (16.3)178 (22.4)< 0.0001
ACEi/ARB618 (37.4)335 (22.1)0.005
Beta-blockers372 (22.5)225 (28.3)< 0.0001
Statins255 (15.4)174 (21.9)< 0.0001


Write to the Help Desk